DIA 2018 Global Annual Meeting
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
Future of PharmaTech
Patrick K Brady, PharmD
Regulatory Policy and Intelligence
Bayer, United States
What is PharmaTech? How is the pharmaceutical and biotech industry evolving with new technologies, such as artifical intelligence (AI) and block chain? How will the business model be impacted? Are there lessons learned from other industries?
This DIAmond session will examine how innovative technologies in drug development are impacting the pharmaceutical and biotech industry.
Learning Objective : Define the concept of PharmaTech and describe it's impact on new technologies and business models; Identify how the pharmaceutical and biotech industry will be impacted by innovative technologies, such as artificial intelligence, in drug development.
National Director, Life Sciences
Microsoft, United States
Dina Katabi, PhD, MS
MIT, United States
Sudip Parikh, PhD
Senior Vice President and Managing Director, DIA Americas
DIA, United States
Henry "Skip" Francis
Director for Data Mining and Informatics Evaluation and Research, OTS, CDER
FDA, United States